Increased Glucose Disposal and AMP-dependent Kinase Signaling in a Mouse Model of Hemochromatosis*
暂无分享,去创建一个
L. Boros | Bai Luo | R. Cooksey | Yudi Soesanto | Deborah L Jones | D. McClain | J. Kushner | J. Gabrielsen | H. Jouihan | Jingyu Huang | M. Hazel | Lauren Knecht | Deborah Jones | Mark W. Hazel
[1] M. Birnbaum,et al. Inhibition of ceramide synthesis ameliorates glucocorticoid-, saturated-fat-, and obesity-induced insulin resistance. , 2007, Cell metabolism.
[2] A. Tuzcu,et al. The correlation between adiposity and adiponectin, tumor necrosis factor α, interleukin-6 and high sensitivity C-reactive protein levels. Is adipocyte size associated with inflammation in adults? , 2007, Journal of endocrinological investigation.
[3] D. McClain,et al. Increased insulin secretory capacity but decreased insulin sensitivity after correction of iron overload by phlebotomy in hereditary haemochromatosis , 2006, Diabetologia.
[4] D. McClain,et al. High prevalence of abnormal glucose homeostasis secondary to decreased insulin secretion in individuals with hereditary haemochromatosis , 2006, Diabetologia.
[5] M. Nishimura,et al. Oxidative stress provokes atherogenic changes in adipokine gene expression in 3T3-L1 adipocytes. , 2006, Biochemical and biophysical research communications.
[6] D. Wallace. A Mitochondrial Paradigm of Metabolic and Degenerative Diseases, Aging, and Cancer: A Dawn for Evolutionary Medicine , 2005, Annual review of genetics.
[7] Y. Terauchi,et al. Serum ferritin is associated with visceral fat area and subcutaneous fat area. , 2005, Diabetes care.
[8] T. Ganz,et al. Hepcidin is decreased in TFR2 hemochromatosis. , 2005, Blood.
[9] B. Lowell,et al. Mitochondrial Dysfunction and Type 2 Diabetes , 2005, Science.
[10] Jerry Kaplan,et al. Hepcidin Regulates Cellular Iron Efflux by Binding to Ferroportin and Inducing Its Internalization , 2004, Science.
[11] R. Cooksey,et al. Oxidative stress, beta-cell apoptosis, and decreased insulin secretory capacity in mouse models of hemochromatosis. , 2004, Endocrinology.
[12] E. Guallar,et al. Serum ferritin and risk of the metabolic syndrome in U.S. adults. , 2004, Diabetes care.
[13] A. Green,et al. Transferrin and iron contribute to the lipolytic effect of serum in isolated adipocytes. , 2004, Diabetes.
[14] J. Widness,et al. Microanalysis of non-heme iron in animal tissues. , 2004, Journal of biochemical and biophysical methods.
[15] H. Boucherie,et al. The Snf1 Protein Kinase Controls the Induction of Genes of the Iron Uptake Pathway at the Diauxic Shift in Saccharomyces cerevisiae* , 2003, Journal of Biological Chemistry.
[16] H. Lodish,et al. Enhanced muscle fat oxidation and glucose transport by ACRP30 globular domain: Acetyl–CoA carboxylase inhibition and AMP-activated protein kinase activation , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[17] S. Uchida,et al. Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase , 2002, Nature Medicine.
[18] L. Bertrand,et al. Insulin and ischemia stimulate glycolysis by acting on the same targets through different and opposing signaling pathways. , 2002, Journal of molecular and cellular cardiology.
[19] Michael T. Postek,et al. Nanometer-scale metrology: meeting the nanotechnology measurement challenges , 2002, Workshop on Nanostructure Science, Metrology, and Technology.
[20] Y. Terauchi,et al. The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity , 2001, Nature Medicine.
[21] R. Gillum. Association of serum ferritin and indices of body fat distribution and obesity in Mexican American men—the Third National Health and Nutrition Examination Survey , 2001, International Journal of Obesity.
[22] C. Scriver. The Metabolic and Molecular Bases of Inherited Disease , 2001 .
[23] D. Carling,et al. Phosphorylation and activation of heart PFK-2 by AMPK has a role in the stimulation of glycolysis during ischaemia , 2000, Current Biology.
[24] Dena E. Cohen,et al. The C282Y mutation causing hereditary hemochromatosis does not produce a null allele. , 1999, Blood.
[25] T. B. Morrison,et al. Quantification of low-copy transcripts by continuous SYBR Green I monitoring during amplification. , 1998, BioTechniques.
[26] R. Wolff,et al. The Hemochromatosis Founder Mutation in HLA-H Disrupts β2-Microglobulin Interaction and Cell Surface Expression* , 1997, The Journal of Biological Chemistry.
[27] S. Bassilian,et al. Isotopomer study of lipogenesis in human hepatoma cells in culture: contribution of carbon and hydrogen atoms from glucose. , 1995, Analytical biochemistry.
[28] TP Millard. Aids to Pathology , 1993 .
[29] W. Lee,et al. Mass isotopomer analysis: theoretical and practical considerations. , 1991, Biological mass spectrometry.
[30] R. Turner,et al. Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man , 1985, Diabetologia.
[31] S. Cushman,et al. Determinations of adipose cell size and number in suspensions of isolated rat and human adipose cells. , 1978, Journal of lipid research.